Artificial Intelligence (AI)-Powered Prosthetics Market Global Report 2026

The artificial intelligence (AI)-powered prosthetics market size has grown rapidly in recent years. It will grow from $1.71 billion in 2025 to $1.99 billion in 2026 at a compound annual growth rate (CAGR) of 16.0%. The growth in the historic period can be attributed to the limited availability of AI technology in prosthetics, the high cost of prosthetic devices, the lack of awareness about advanced prosthetics, the continued use of traditional rehabilitation practices, and low adoption in emerging regions.

The artificial intelligence (AI)-powered prosthetics market size is expected to see rapid growth in the next few years. It will grow to $3.56 billion in 2030 at a compound annual growth rate (CAGR) of 15.7%. The growth during the forecast period can be attributed to advancements in AI and machine learning algorithms, growing investment in robotic and myoelectric prosthetics, increasing demand from sports and military applications, expansion of prosthetic clinics and rehabilitation centers, and improvements in healthcare infrastructure and insurance coverage. Major trends in the forecast period include increasing demand for personalized prosthetics, integration of sensor-based feedback systems, expansion of rehabilitation and mobility programs, growing adoption of sports and military prosthetics, and increasing focus on cosmetic and aesthetic prosthetics.

The increasing incidence of diabetes is anticipated to support the expansion of the artificial intelligence (AI)-powered prosthetics market going forward. Diabetes is a chronic condition characterized by persistently elevated blood sugar levels because the body does not produce sufficient insulin or is unable to use insulin effectively. The incidence of diabetes is rising significantly due to sedentary lifestyles, as limited physical activity reduces metabolism and promotes weight gain, thereby increasing the risk of insulin resistance. Diabetes-related complications, including poor blood circulation and nerve damage, may lead to limb amputations, increasing the demand for AI-powered prosthetics that help restore mobility and improve patients’ quality of life. For instance, in June 2024, according to the National Health Service, a UK-based publicly funded healthcare system, in 2023, the number of individuals identified by the NHS in England as having pre-diabetes increased to 3,615,330, representing an 18% rise from 3,065,825 in 2022. Additionally, among individuals below the age of 40, cases increased by nearly 25%, rising from 173,166 in 2022 to 216,440 in 2023. Therefore, the increasing incidence of diabetes is contributing to the expansion of the artificial intelligence (AI)-powered prosthetics market.

Key companies operating in the artificial intelligence (AI)-powered prosthetics market are focusing on developing innovative approaches, such as neural interface integration, to improve limb functionality, enhance user adaptability, and provide amputees with near-natural mobility across everyday and specialized activities. Neural interface integration refers to AI-driven systems that interpret brain or muscle signals through machine learning algorithms and sensor networks, designed to facilitate real-time, intuitive control of prosthetic limbs with life-like characteristics such as precision and responsiveness. For example, in May 2025, Esper Bionics, a Ukraine-based bionic prosthetics company, launched its Esper Hand 2, a waterproof, AI-powered prosthetic hand that adapts to user behavior, provides advanced grip strength, and functions effectively in challenging environments, including rain. This launch represents a significant advancement in assistive prosthetic technology, providing users with an intelligent and durable solution designed to improve real-world functionality and daily life performance.

In February 2024, Nippon Express Holdings, a Japan-based logistics and transportation company, acquired an equity stake in Instalimb Inc. for an undisclosed amount. Through this acquisition, Nippon Express aims to support Instalimb’s global expansion and enhance access to affordable, AI-driven 3D-printed prosthetic solutions in emerging markets through improved logistics capabilities. Instalimb Inc. is a Japan-based startup specializing in ultra-low-cost, high-quality 3D-printed prosthetic devices, leveraging 3D printing and AI to expand access to prosthetics.

Major companies operating in the artificial intelligence (AI)-powered prosthetics market are Ottobock SE & Co. KGaA, Össur hf, Blatchford Limited, BrainCo Inc., BrainRobotics Inc., Open Bionics Ltd., Point Designs Inc., Ambionics Ltd., Coapt LLC, Vincent Systems GmbH, PSYONIC Inc., BionIT Labs Ltd., Aether Biomedical Inc., BionicM Inc., Esper Bionics Inc., Mobius Bionics LLC, Covvi Limited, Unlimited Tomorrow Inc., Prensilia S.r.l., Bioniks Pvt. Ltd.

North America was the largest region in the artificial intelligence (AI)-powered prosthetics market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the artificial intelligence (AI)-powered prosthetics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the artificial intelligence (AI)-powered prosthetics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

This product will be delivered within 3-5 business days.